L-Asparaginase Suppliers & Bulk Manufacturers
Available Forms: IV Infusion and IV/ IM Injection
Available Strengths: 10,000 IU/vial (IV or IM injection); 2,500 IU/vial (IV infusion)
Reference Brands: Elspar® , Asparlas®, Erwinase® (US & EU)
Category:
Oncology Cancer Care
L-asparaginase is used to treat acute lymphoblastic leukemia (ALL) and lymphomas by depleting the amino acid asparagine. Available under brands like Elspar®, Asparlas®, and Erwinase®, it comes in strengths such as 10,000 IU/vial and 2,500 IU/vial. Administered via IV or IM injection, it is widely sourced by B2B pharmaceutical wholesalers in the US and EU, ensuring reliable, GMP-compliant supply and competitive pricing for oncology centers.
L-asparaginase is available in IV Infusion and IV/ IM Injection
and strengths such as 10,000 IU/vial (IV or IM injection); 2,500 IU/vial (IV infusion).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, L-asparaginase is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
L-asparaginase can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
L-asparaginase is an essential enzyme-based chemotherapy used in the treatment of acute lymphoblastic leukemia (ALL) and lymphomas. It works by depleting asparagine, an amino acid needed for cancer cell survival. Available under brands like Elspar®, Asparlas®, and Erwinase®, it is offered in strengths such as 10,000 IU/vial and 2,500 IU/vial. Administered via intravenous (IV) or intramuscular (IM) injection, L-asparaginase is widely sourced by B2B pharmaceutical wholesalers in the US and EU. These therapies ensure reliable GMP-compliant distribution for oncology centers, offering competitive pricing and consistent supply for cancer treatment.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing